JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production.
LaBranche TP, Jesson MI, Radi ZA, Storer CE, Guzova JA, Bonar SL, Thompson JM, Happa FA, Stewart ZS, Zhan Y, Bollinger CS, Bansal PN, Wellen JW, Wilkie DP, Bailey SA, Symanowicz PT, Hegen M, Head RD, Kishore N, Mbalaviele G, Meyer DM.
LaBranche TP, et al. Among authors: mbalaviele g.
Arthritis Rheum. 2012 Nov;64(11):3531-42. doi: 10.1002/art.34649.
Arthritis Rheum. 2012.
PMID: 22899318
Free article.